291 related articles for article (PubMed ID: 26350318)
1. Metabolism and Pathogenicity of Pseudomonas aeruginosa Infections in the Lungs of Individuals with Cystic Fibrosis.
Palmer GC; Whiteley M
Microbiol Spectr; 2015 Aug; 3(4):. PubMed ID: 26350318
[TBL] [Abstract][Full Text] [Related]
2. Desulfurization of mucin by Pseudomonas aeruginosa: influence of sulfate in the lungs of cystic fibrosis patients.
Robinson CV; Elkins MR; Bialkowski KM; Thornton DJ; Kertesz MA
J Med Microbiol; 2012 Dec; 61(Pt 12):1644-1653. PubMed ID: 22918866
[TBL] [Abstract][Full Text] [Related]
3. In vivo evidence of Pseudomonas aeruginosa nutrient acquisition and pathogenesis in the lungs of cystic fibrosis patients.
Son MS; Matthews WJ; Kang Y; Nguyen DT; Hoang TT
Infect Immun; 2007 Nov; 75(11):5313-24. PubMed ID: 17724070
[TBL] [Abstract][Full Text] [Related]
4. [Infections of the respiratory tract with Pseudomonas aeruginosa in cystic fibrosis].
Winkler U; Wingender J; Jäger KE
Klin Wochenschr; 1985 Jun; 63(11):490-8. PubMed ID: 3925219
[TBL] [Abstract][Full Text] [Related]
5. Clinical implications of Pseudomonas aeruginosa location in the lungs of patients with cystic fibrosis.
Moore JE; Mastoridis P
J Clin Pharm Ther; 2017 Jun; 42(3):259-267. PubMed ID: 28374433
[TBL] [Abstract][Full Text] [Related]
6. Utilization of human respiratory secretions by mucoid Pseudomonas aeruginosa of cystic fibrosis origin.
Ohman DE; Chakrabarty AM
Infect Immun; 1982 Aug; 37(2):662-9. PubMed ID: 6811437
[TBL] [Abstract][Full Text] [Related]
7. Marker genes for the metabolic adaptation of Pseudomonas aeruginosa to the hypoxic cystic fibrosis lung environment.
Eichner A; Günther N; Arnold M; Schobert M; Heesemann J; Hogardt M
Int J Med Microbiol; 2014 Nov; 304(8):1050-61. PubMed ID: 25130702
[TBL] [Abstract][Full Text] [Related]
8. The Small RNA ErsA Plays a Role in the Regulatory Network of Pseudomonas aeruginosa Pathogenicity in Airway Infections.
Ferrara S; Rossi A; Ranucci S; De Fino I; Bragonzi A; Cigana C; Bertoni G
mSphere; 2020 Oct; 5(5):. PubMed ID: 33055260
[TBL] [Abstract][Full Text] [Related]
9. Effect of Shear Stress on Pseudomonas aeruginosa Isolated from the Cystic Fibrosis Lung.
Dingemans J; Monsieurs P; Yu SH; Crabbé A; Förstner KU; Malfroot A; Cornelis P; Van Houdt R
mBio; 2016 Aug; 7(4):. PubMed ID: 27486191
[TBL] [Abstract][Full Text] [Related]
10. Pseudomonas aeruginosa Volatilome Characteristics and Adaptations in Chronic Cystic Fibrosis Lung Infections.
Davis TJ; Karanjia AV; Bhebhe CN; West SB; Richardson M; Bean HD
mSphere; 2020 Oct; 5(5):. PubMed ID: 33028687
[No Abstract] [Full Text] [Related]
11. The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way?
Banerjee D; Stableforth D
Drugs; 2000 Nov; 60(5):1053-64. PubMed ID: 11129122
[TBL] [Abstract][Full Text] [Related]
12. Microevolution of Pseudomonas aeruginosa to a chronic pathogen of the cystic fibrosis lung.
Hogardt M; Heesemann J
Curr Top Microbiol Immunol; 2013; 358():91-118. PubMed ID: 22311171
[TBL] [Abstract][Full Text] [Related]
13. Use of a Multiplex Transcript Method for Analysis of Pseudomonas aeruginosa Gene Expression Profiles in the Cystic Fibrosis Lung.
Gifford AH; Willger SD; Dolben EL; Moulton LA; Dorman DB; Bean H; Hill JE; Hampton TH; Ashare A; Hogan DA
Infect Immun; 2016 Oct; 84(10):2995-3006. PubMed ID: 27481238
[TBL] [Abstract][Full Text] [Related]
14. Iron acquisition by Pseudomonas aeruginosa in the lungs of patients with cystic fibrosis.
Lamont IL; Konings AF; Reid DW
Biometals; 2009 Feb; 22(1):53-60. PubMed ID: 19130260
[TBL] [Abstract][Full Text] [Related]
15. Relative contribution of Prevotella intermedia and Pseudomonas aeruginosa to lung pathology in airways of patients with cystic fibrosis.
Ulrich M; Beer I; Braitmaier P; Dierkes M; Kummer F; Krismer B; Schumacher U; Gräpler-Mainka U; Riethmüller J; Jensen PØ; Bjarnsholt T; Høiby N; Bellon G; Döring G
Thorax; 2010 Nov; 65(11):978-84. PubMed ID: 20880875
[TBL] [Abstract][Full Text] [Related]
16. Calprotectin-Mediated Zinc Chelation Inhibits Pseudomonas aeruginosa Protease Activity in Cystic Fibrosis Sputum.
Vermilyea DM; Crocker AW; Gifford AH; Hogan DA
J Bacteriol; 2021 Jun; 203(13):e0010021. PubMed ID: 33927050
[TBL] [Abstract][Full Text] [Related]
17. Harnessing Neutrophil Survival Mechanisms during Chronic Infection by
Marteyn BS; Burgel PR; Meijer L; Witko-Sarsat V
Front Cell Infect Microbiol; 2017; 7():243. PubMed ID: 28713772
[TBL] [Abstract][Full Text] [Related]
18. Flagellin induces myeloid-derived suppressor cells: implications for Pseudomonas aeruginosa infection in cystic fibrosis lung disease.
Rieber N; Brand A; Hector A; Graepler-Mainka U; Ost M; Schäfer I; Wecker I; Neri D; Wirth A; Mays L; Zundel S; Fuchs J; Handgretinger R; Stern M; Hogardt M; Döring G; Riethmüller J; Kormann M; Hartl D
J Immunol; 2013 Feb; 190(3):1276-84. PubMed ID: 23277486
[TBL] [Abstract][Full Text] [Related]
19. Anti-PcrV antibody in cystic fibrosis: a novel approach targeting Pseudomonas aeruginosa airway infection.
Milla CE; Chmiel JF; Accurso FJ; VanDevanter DR; Konstan MW; Yarranton G; Geller DE;
Pediatr Pulmonol; 2014 Jul; 49(7):650-8. PubMed ID: 24019259
[TBL] [Abstract][Full Text] [Related]
20. Pseudomonas aeruginosa microevolution during cystic fibrosis lung infection establishes clones with adapted virulence.
Bragonzi A; Paroni M; Nonis A; Cramer N; Montanari S; Rejman J; Di Serio C; Döring G; Tümmler B
Am J Respir Crit Care Med; 2009 Jul; 180(2):138-45. PubMed ID: 19423715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]